Zura Bio Limited Class A Ordinary Shares (ZURA NASDAQ) stock market data APIs
$3.9341
0.07(1.8%)
as of November 2, 2026
Try our APIs with
free plan!
Zura Bio Limited Class A Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Prev. Close
3.9341
Open
4.0083
High
4.1733
Low
3.8535
52 wk Range
3.25-7.44
Market Cap
389 M
Shares Outstanding
96 325 K
EPS
-0.2
Beta
0.009
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Zura Bio Limited Class A Ordinary Shares (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Zura Bio Limited Class A Ordinary Shares data using free add-ons & libraries
Get Zura Bio Limited Class A Ordinary Shares Fundamental Data
Zura Bio Limited Class A Ordinary Shares Fundamental data includes:
- Net Revenue:
- EBITDA: -101 937 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Zura Bio Limited Class A Ordinary Shares Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-10-27
- EPS/Forecast: -0.22
Get Zura Bio Limited Class A Ordinary Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zura Bio Limited Class A Ordinary Shares News
New
Zura Bio GAAP EPS of -$0.20 in-line
* Zura Bio press release [https://seekingalpha.com/pr/20700912-zura-bio-reports-third-quarter-2026-financial-results-and-recent-corporate-updates] (ZURA [https://seekingalpha.com/symbol/ZURA]): Q3 G...
This biotech stock is a top pick at Guggenheim
Investing.com-- Guggenheim named Zura Bio a top pick in the biotechnology sector, reiterating its Buy rating and $20 price target ahead of the company's Phase II TibuSHIELD readout in hidradenitis sup...
Zura Bio (ZURA) Hits Enrollment Milestones As Losses Widen Sharply
On August 11, Zura Bio (NASDAQ:ZURA) reported second-quarter results that landed on an unusual mix of good and bad news. The clinical-stage biotech finished enrolling two separate Phase 2 studies of i...
William Blair Starts Zura Bio (ZURA) at Outperform
Zura Bio Limited (NASDAQ:ZURA) is one of the 10 High Growth Stocks Insiders Are Buying. On July 8, 2026, William Blair initiated coverage of Zura Bio Limited (NASDAQ:ZURA) with an Outperform rating. ...
Get Zura Bio Limited Class A Ordinary Shares fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.